Congratulations to Mario Otto, MD, PhD, for his recent award from Alex’s Lemonade Stand Foundation for his project, “Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ether Analogue and its Multifunctional Cancer-targeting Nanoconstruct.” Through this $100,000 award over 2 years, Dr. Otto aims to evaluate whether NM404 is a novel, unconventional tumor-selective anticancer agent suitable for the treatment of neuroblastoma and other pediatric cancers, either as a single agent or in form of a colloidal, inorganic nanoconstruct. This proposal hopes to generate necessary pre-clinical data leading to upcoming clinical trials.